NEW YORK, Oct 1 (Reuters) – A Trump administration rule to cut hospital drug prices for Medicare patients may apply to as few as four drugmakers after exempting companies that signed separate “most favored nation” pricing agreements with the administration, according to the finalized rule. According
By Sneha S K and Siddhi Mahatole Oct 1 (Reuters) – A panel of advisers to the US FDA on Thursday recommended the virus strains vaccine manufacturers should include for the 2027 southern hemisphere influenza season. The Vaccines and Related Biological Products Advisory Committee recommended that the
Oct 1 (Reuters) – Florida Attorney General James Uthmeier on Thursday filed a lawsuit against Pfizer and its CEO, Albert Bourla, accusing the drugmaker of misleading consumers about the safety and effectiveness of its COVID-19 vaccine. Here are more details: • Uthmeier filed the lawsuit in state cou
By Emma Farge and Clement Bonnerot GENEVA/DAKAR, Oct 1 (Reuters) – Thousands of displaced residents at an Ebola-hit camp in eastern Democratic Republic of Congo have fled after soldiers entered the site, UN and Congolese officials said on Thursday, raising concern about the disease’s spread. • Secur
(Dallas, TX) — President Trump is sending out 500-dollar Obamacare refunds to some enrollees starting today. Nearly a million people are eligible in 30 states that use the federally-operated exchange to buy insurance plans under the Affordable Care Act, the formal name for Obamacare. The money comes
Oct 1 (Reuters) – Foghorn Therapeutics said on Thursday it has discontinued development of an experimental cancer drug partnered with Eli Lilly after it failed to show enough benefit in an early-stage trial. The companies will not extend their 2021 partnership, originally valued at up to $1.6 billio
GENEVA/AMSTERDAM, Oct 1 (Reuters) – A Médecins Sans Frontières staff member working on the Ebola response in the Democratic Republic of Congo has contracted the Ebola Bundibugyo virus and is being evacuated to the Netherlands for treatment, the humanitarian organisation said on Thursday. “This perso
Oct 1 (Reuters) – Nearly one in five patients quit Zealand Pharma’s late-stage survodutide trial due to gastrointestinal side effects caused by the obesity drug, data released on Thursday showed, again raising investor concerns over the high dropout rates. The Danish drugmaker’s shares slid as much
By Amina Niasse NEW YORK, Oct 1(Reuters) – US health insurers including UnitedHealthcare and CVS Health’s Aetna will shift to offer more Medicare Advantage plans that limit provider access for enrolled users, the companies said on Thursday. “We can’t ignore the realities facing the healthcare system
AMSTERDAM, Oct 1 (Reuters) – Four more people in the Netherlands have died from an infection caused by the West Nile virus in recent weeks, the public health institution RIVM said on Thursday, following an increased number of cases in Europe. • The new fatalities increased the total number of people
By Ruma Paul DHAKA, Oct 1 (Reuters) – Bangladesh enters October facing a worsening dengue outbreak after its deadliest month this year, as experts warned that weather conditions could fuel further spread, piling pressure on hospitals already fighting the world’s worst measles outbreak. The resurgenc
Oct 1 (Reuters) – Sanofi and US partner Regeneron on Thursday said they would expand their partnership to develop four new drugs, in a deal that includes up to $7 billion in milestone payments. Sanofi will pay Regeneron $1 billion upfront, with additional payments tied to development, regulatory and
(Undated) — The remnants of a former Pacific hurricane is causing a flood threat in the central U.S. Polo is centered over northern Mexico, but the remnants of the former Category 5 hurricane have been causing heavy rain and flooding across the Southwest. Moisture from the storm is now heading towar
By Sriparna Roy Sept 30 (Reuters) – An experimental weight-loss drug being developed by Regeneron used in combination with Novo Nordisk’s semaglutide reduced the loss of muscle mass by 50% compared with the loss seen with semaglutide alone in a study of patients with obesity, according to data being
Sept 30 (Reuters) – Liquidia shares plunged nearly 50% on Wednesday after a federal judge ruled that its lung drug infringes key patent held by rival United Therapeutics, dealing a major blow to the treatment’s commercial outlook. The US District Court for the District of Delaware found that Liquidi
Sept 30 (Reuters) – Walgreens-owner Sycamore Partners is close to a deal to sell British pharmacy chain Boots to the Weston family for about $9 billion, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. The deal could be completed in the coming weeks if talks do
Sept 30 (Reuters) – Pennsylvania’s health department reported 943 measles cases as of Wednesday, according to its website, as the state grapples with a growing outbreak of the highly contagious disease. Here are some key details: • Pennsylvania reported four measles-related deaths among unvaccinated
Sept 30 (Reuters) – The US Food and Drug Administration on Wednesday launched a nationwide effort to recruit scientists, medical experts and consumer representatives to its advisory committees, which advise the agency on drugs, vaccines and other regulated products. Here are few details: • The agenc
By Patrick Wingrove Sept 30 (Reuters) – Eli Lilly said on Wednesday its experimental combination weight-loss drug outperformed its blockbuster Zepbound in a head-to-head trial, intensifying the competition with Danish rival Novo Nordisk for new, more effective obesity therapies. The Indianapolis-bas
By Sahil Pandey Sept 30 (Reuters) – Merck said on Wednesday its experimental drug significantly reduced inflammatory skin lesions in patients with a chronic skin disease, meeting the main goal of a mid-stage study. The results bolster Merck’s push into immunology and could position the drug, tulisok
(Corrects headline and paragraph 1 to clarify that Cigna is not investing $3 billion, but expecting that amount in cost savings by 2030) Sept 30 (Reuters) – Cigna on Wednesday announced a new program that aims to deliver about $3 billion in cost savings by 2030 by focusing on modernizing processes a
By Joey Roulette WASHINGTON, Sept 30 (Reuters) – In-space manufacturing startup Varda Space has raised $250 million in a Series D round at a $1.6 billion valuation, the company told Reuters, as it ramps up missions to produce pharmaceuticals in microgravity. El Segundo-based Varda is one of a handfu
By Patrick Wingrove Sept 30 (Reuters) – Patients who switched from weight-loss injections to Novo Nordisk’s daily Wegovy pill continued to lose weight, according to data unveiled at a medical meeting on Wednesday, as the Danish drugmaker seeks to defend its lead over US rival Eli Lilly in the market
Sept 30 (Reuters) – Gerresheimer reported a sequential recovery in its second-quarter revenue on Wednesday, sending its shares 8% higher in early trading, as demand for its drug delivery devices boosted sales. The German drug-packaging maker reported preliminary revenue of €578 million ($656.09 mill
(Dallas, TX) — A Flood Watch is covering 12 states across the Midwest into the Plains and Southwest. Tropical moisture from Hurricane Polo is fueling the flood threat through Wednesday in the Southwest and Central U.S. And across Texas, the Southern Plains and the Midwest, moisture from Tropical Sto
Monsoon Rains Leave at Least 90 Dead in India, Nepal, Myanmar By The Media Line Staff At least 62 people have died, 46 were injured and 1,000 homes were destroyed after heavy monsoon rains triggered flooding in India’s northern Uttar Pradesh state, officials said Monday. Some reports put the death t
By Mariko Katsumura TOKYO, Sept 30 (Reuters) – Japan has started its first nationwide survey of animal cafes amid concerns over animal welfare, hygiene and public health, a government official said, bringing greater scrutiny to the popular but lightly regulated sector. The desktop survey, which bega
Sept 29 (Reuters) – Eli Lilly said on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial. (Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar) Brought to you by www.srnnews.
By Dietrich Knauth NEW YORK, Sept 29 (Reuters) – Attorneys for three cancer patients told a Missouri jury on Tuesday that Bayer’s Monsanto unit failed to adequately test its Roundup weedkiller before selling it, starting a trial that could help determine the viability of some Roundup lawsuits after
Sept 29 (Reuters) – Two Indian nationals have been indicted by a US federal grand jury for allegedly smuggling and selling counterfeit Ozempic, the weight-loss drug, the Department of Justice said on Tuesday. One of the defendants, Swapnadip Roy, pleaded not guilty after being extradited from Italy
